Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 1/2 study evaluating the safety and efficacy of PN20 for thrombocytopenia in patients with chronic liver disease un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia Associated with Chronic Liver Disease

Drugs mentioned

• PN20

Snippet

Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. | Conditions: Thrombocytopenia Associated With Chronic Liver Disease | Phase 1, Phase 2 | Status: RECRUITING